368 related articles for article (PubMed ID: 25384535)
21. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
Sharma VK; Prasad HR; Khandpur S; Kumar A
Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
[TBL] [Abstract][Full Text] [Related]
23. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
[TBL] [Abstract][Full Text] [Related]
24. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.
Ohyama M; Amagai M; Hashimoto T; Nousari HC; Anhalt GJ; Nishikawa T
J Am Acad Dermatol; 2001 Apr; 44(4):593-8. PubMed ID: 11260531
[TBL] [Abstract][Full Text] [Related]
25. Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
Bhatia SM; Streilein RD; Hall RP
PLoS One; 2020; 15(6):e0233957. PubMed ID: 32555697
[TBL] [Abstract][Full Text] [Related]
26. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
27. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
[TBL] [Abstract][Full Text] [Related]
28. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
[TBL] [Abstract][Full Text] [Related]
30. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
Schmidt E; Dähnrich C; Rosemann A; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Hashimoto T; Bröcker EB; Recke A; Rose C; Zillikens D
Exp Dermatol; 2010 May; 19(5):458-63. PubMed ID: 20163452
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
32. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
[TBL] [Abstract][Full Text] [Related]
33. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
Ishii K; Amagai M; Hall RP; Hashimoto T; Takayanagi A; Gamou S; Shimizu N; Nishikawa T
J Immunol; 1997 Aug; 159(4):2010-7. PubMed ID: 9257868
[TBL] [Abstract][Full Text] [Related]
34. Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris.
Dhandha MM; Seiffert-Sinha K; Sinha AA
Autoimmunity; 2012 Nov; 45(7):516-26. PubMed ID: 22779708
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
[TBL] [Abstract][Full Text] [Related]
36. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.
De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW
Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318
[TBL] [Abstract][Full Text] [Related]
37. Recalcitrant facial pemphigus vulgaris: correlation of skin lesions with the ratio of antidesmoglein antibodies 1 and 3.
Fujii M; Honma M; Iinuma S; Kaneta K; Komatsu S; Sato K; Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2011 Apr; 36(3):284-7. PubMed ID: 21418270
[TBL] [Abstract][Full Text] [Related]
38. Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.
Fujio Y; Kojima K; Hashiguchi M; Wakui M; Murata M; Amagai M; Yamagami J
J Dermatol Sci; 2017 Mar; 85(3):208-215. PubMed ID: 28012821
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Importance of Immunological Profile for Pemphigus Vulgaris in the Light of Necessity to Modify Compensation Theory.
Öktem A; Hayran Y; Uysal Pİ; Atılan AU; Yalçın B
Acta Dermatovenerol Croat; 2018 Jun; 26(2):100-104. PubMed ID: 29989864
[TBL] [Abstract][Full Text] [Related]
40. Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules.
Ohyama B; Nishifuji K; Chan PT; Kawaguchi A; Yamashita T; Ishii N; Hamada T; Dainichi T; Koga H; Tsuruta D; Amagai M; Hashimoto T
J Invest Dermatol; 2012 Apr; 132(4):1158-68. PubMed ID: 22277941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
